-
Kazia Therapeutics NASDAQ:KZIA
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
144.8M
Cash
3.563M
Avg Qtr Burn
-3.171M
Short % of Float
0.13%
Insider Ownership
0.00%
Institutional Own.
1.47%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Paxalisib (GDC-0084) (PI3K pathway) Details Glioblastoma | Phase 2/3 Data readout | |
Phase 2 Data readout | ||
Paxalisib (GDC-0084) (PI3K pathway) Details primary central nervous system lymphomas | Phase 2 Update | |
EVT801 Details Solid tumor/s, Cancer | Phase 1 Data readout | |
Cantrixil (TRX-E-002-1) Details Ovarian cancer | Failed Discontinued |